Ideaship, a venture capital firm by Global Technology Transfer Group, has teamed up with Droplet Biosciences
to advance cancer research and treatment. Droplet Bioscience’s non-invasive lymph liquid biopsy technique offers crucial insights into the lymphatic system, helping to make informed decisions about post-surgery treatment.
Droplet’s lymph liquid biopsy procedure targets the nodes closest to the tumor, immediately after surgery, providing astounding accuracy when fighting cancer metastasis.
We are thrilled about this investment and the potential it holds to revolutionize cancer care and improve patient outcomes.
To learn more about Droplet Biosciences visit their website